Michelle Introduces new drugs for cardiovascular diseases

Michelle Laboratories Limited has introduced two new pharmaceutical products to the market. These products are Cardiovascular drugs. i.e. My-Oprin & Cikaretic.

The product manager of the company disclosed this at a round table discussion on the cause and cure for ravaging cardiovascular diseases in our society; saying the move was aimed at ensuring a cost-effective and available medicine to patients. According to him, the company spends a lot of money on research and development before coming up with these products.